Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Novel catalytic route for trifluoromethyl spiro oxindoles offering high stereoselectivity and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN102285896B details a novel chloramphenicol synthesis using benzaldehyde, offering high purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN112739683B reveals a novel Brivaracetam synthesis using Quinine catalysts. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103896816A reveals advanced Ir-catalyzed synthesis for chiral allyl thiocarboxylates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Patent CN1473832A details a novel catalytic synthesis for d-biotin intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN107032972B details a catalytic asymmetric Diels-Alder route for flavonoid intermediates, offering high enantioselectivity and simplified purification for pharmaceutical manufacturing.
Patent CN109666030B details a novel spirocyclic amine catalyzed route for codeine and morphine, offering high enantioselectivity and supply chain independence from poppy cultivation.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN105906649B details asymmetric synthesis of chiral spirolides. Offers high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN116135835B reveals a novel copper-catalyzed asymmetric cyclopropanation method. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability for global buyers.
Novel preparation of cis-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid via asymmetric addition. Enhances catalytic efficiency and reduces manufacturing costs for high-purity intermediates.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Patent CN109942553B discloses a one-step asymmetric synthesis of chiral 3,4,6-trisubstituted tetrahydro-2H-pyran-2-ones using chiral secondary amine catalysts, offering high enantioselectivity and operational simplicity for pharmaceutical manufacturing.
Patent CN102984945B details a high-yield asymmetric hydrogenation process for Ramipril and Perindopril intermediates, offering significant cost and purity advantages for pharmaceutical supply chains.